Skip to main content

Table 4 Multivariate analyses of factors associated with bone metastasis in 157 HCC patients

From: Serum lnc34a is a potential prediction biomarker for bone metastasis in hepatocellular carcinoma patients

Variable

Bone metastasis

HR (95% CI)

P

Vascular invasion (no versus yes)

6.625(2.291–19.157)

< 0.001

BCLC stage (0-A versus B-C)

3.910(1.244–12.287)

0.020

Lnc34a (low versus high)

3.883(1.107–13.629)

0.034

  1. HCC hepatocellular carcinoma, BCLC-stage Barcelona Clinic Liver Cancer-stage